在KCNH3中的功能丧失变体与全球发育迟缓,自闭症行为,失眠和夜间发作有关
Christiane K Bauer1, Fanny Kortüm2, Anna Möllring2
1Institute of Cellular and Integrative Physiology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Seizure
|March 29, 2025
概括
编码Kv12.2通道的KCNH3的致病变体会导致神经发育障碍,包括发作. 这项研究确定了一种与儿童智力障碍和有关的新型KCNH3变异.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 道病变是一种通道病变.
背景情况:
- KCNH基因家族编码电压通道 (Kv),对神经元和心脏功能至关重要.
- Kv10和Kv11亚家族基因中的致病变体与心律失常和神经发育综合征有关.
- 在本研究之前,对编码Kv12亚家族成员的KCNH基因没有报告任何致病变体.
研究的目的:
- 为了研究一个八岁女孩严重的神经发育障碍的遗传基础.
- 在KCNH基因家族中识别新型疾病相关基因,特别针对Kv12亚家族.
主要方法:
- 临床评估,包括神经学评估和的特征.
- 三个外基因组测序用于识别新的遗传变异.
- 在Xenopus卵细胞中使用电压电生理学的功能研究来评估通道功能.
主要成果:
- 在KCNH3中发现了一种异合的de novo误解变异 (c.1112C>T; p.(Ala371Val)) 编码Kv12.2通道.
- 该患者出现了全球发育迟缓,智力障碍,行为问题和夜间发作.
- 电生理学分析揭示了KCNH3 p.(Ala371Val) 变体的功能丧失表型,表现出主导负面效应.
结论:
- 建议KCNH3作为一种与神经发育障碍相关的新型疾病基因,包括.
- 鉴定到的KCNH3变异导致Kv12.2通道的功能丧失,导致患者的表型.
- 这一发现扩大了KCNH通道病变的范围,包括Kv12亚家族.
相关概念视频
Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


